Detail-oriented researcher with expertise in ligand-protein interactions, focusing on the design of innovative anti-cancer drugs based on adamantane. Proficient in HPLC method development and validation using WATERS and Agilent instruments, demonstrating a strong analytical vision. Aiming to leverage skills in drug design and analytical techniques to contribute to advancements in pharmaceutical research.